Elucidation of the cell cycle checkpoint mechanisms in mammalian cells
Elucidation of the cell cycle checkpoint mechanisms in mammalian cells
批准号:
11470035
负责人:
NAKANISHI Makoto
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The transmission of genetic information relies on checkpoint responses to errors affecting the integrity, replication, and segregation of the genome. A defect in checkpoint mechanisms can result in genetic instability and lead to the transformation of normal cells into cancer cells. Many genes that contribute to checkpoint mechanisms were initially identified in fission or budding yeast as a result of mutations that disrupt cell cycle checkpoints, and the recent discovery of their mammalian counterparts has suggested the conservation of checkpoint mechanisms between yeast and mammals. In fission yeast, the protein kinases Chk1 and Cds1 cooperatively function in cell cycle arrest upon DNA damage through regulating Cdc25. However, the functions of these kinases in mammals have remained unknown. Targeted disruption of Chk1 and Cds1 genes in mice revealed that Chk1-/- mice exhibited early embryonic lethality before E7.5 and its embryos exhibit gross morphologic abnormalities in nuclei as early as the blastocyst stage. DNA replication block and DNA damage failed to arrest the cell cycle before initiation of mitosis in Chk1-/- embryos. Thus, Chk1 is indispensable for cell proliferation and survival through maintaining the G2/M checkpoints in mammals. In contrast, Cds1-/- mice were viable and fertile, and its MEFs did not show the remarkable defects in G2/M checkpoints. Alternatively, Cds1-/- thymocytes were resistant to IR-induced and p53-dependent apoptosis. Taken together, these results clearly suggest that, in mammals, Chk1 and Cds1 kinases play important roles in distinct signal pathways upon DNA damage through regulating Cdc25 and p53, respectively.
期刊论文(119)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fuse,T.: "p27^<Kip1> expression by contact inhibition as a prognostic index of human glioma."J.Neurochem.. 74. 1393-1399 (2000)
Fuse,T.:“接触抑制的 p27^<Kip1> 表达作为人类神经胶质瘤的预后指标。”J.Neurochem.. 74. 1393-1399 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mitsui,K: "A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins."Biochem.Biophys.Res.Commun.. 266. 115-122 (1999)
Mitsui,K:“编码 HECT 结构域和 RCC1 样重复序列的新型人类基因与细胞周期蛋白相互作用,并可能受到肿瘤抑制蛋白的调节。”Biochem.Biophys.Res.Commun.. 266. 115-122 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fuse, T., Tanikawa, M., Nakanishi, M., Ikeda, K., Tada, T., Inagaki, H., Asai, K., Kato, T., Yamada, K.: "P27^<Kip1> expression by contact inhibition as a prognostic index of human glioma."J.Neurochem. 74. 1393-1399 (2000)
Fuse, T.、Tanikawa, M.、Nakanishi, M.、Ikeda, K.、Tada, T.、Inagaki, H.、Asai, K.、Kato, T.、Yamada, K.:“P27^<Kip1
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mitsui, K., Nakanishi, M., Ohtsuka, S., Norwood, T.H., Obayashi, K., Miyamoto, C., Tanaka, K., Yoshimura, A., Ohtsubo, M.: "A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor supp
Mitsui, K.、Nakanishi, M.、Ohtsuka, S.、Norwood, T.H.、Obayashi, K.、Miyamoto, C.、Tanaka, K.、Yoshimura, A.、Ohtsubo, M.:“编码新的人类基因
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kaneko,Y.: "Phorbol ester inhibits DNA damage-induced apoptosis in U937 cells through activation of protein kinase C."Life Science. 65. 2251-2258 (1999)
Kaneko,Y.:“佛波酯通过激活蛋白激酶 C 抑制 U937 细胞中 DNA 损伤诱导的细胞凋亡。”生命科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 46 条
Development of a New Synthesis Method Mimicking Iron-oxidizing Bacteria for Highly Chromatic Inorganic Pigments
-
批准号:20K21238
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.08万
-
财政年份:2020
-
负责人:NAKANISHI Makoto
-
依托单位:
Establishment of damage dose-dependent senescence inducible system and its application for understanding molecular basis underlying geriatiric diseases
-
批准号:24659137
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:NAKANISHI Makoto
-
依托单位:
Mechanism of premature senescence induction through DNA damage responses
-
批准号:23240124
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.62万
-
财政年份:2011
-
负责人:NAKANISHI Makoto
-
依托单位:
A study on teaching haiku to nurture aesthetic sensitivity and communication competence
-
批准号:23531208
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2011
-
负责人:NAKANISHI Makoto
-
依托单位:
Mechanisms of transcriptional repression in response to genome stress-role of histone H3 phosphorylation at T11-
-
批准号:20390083
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.56万
-
财政年份:2008
-
负责人:NAKANISHI Makoto
-
依托单位:
A study on instruction haiku to nurture sensitivity and communication competence
-
批准号:19530824
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:2007
-
负责人:NAKANISHI Makoto
-
依托单位:
The role of steroid receptor coactivator (SRC) in the development of prostate cancer
-
批准号:14571512
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:NAKANISHI Makoto
-
依托单位:
Development of novel anti-inflammatory drugs on the basis of prostaglandin A1 structure
-
批准号:13557043
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2001
-
负责人:NAKANISHI Makoto
-
依托单位:
A theoretical and empirical investigation of writing instruction with the aim of facilitating text generation processes
-
批准号:13680314
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:2001
-
负责人:NAKANISHI Makoto
-
依托单位:
Elucidation of the mechanisms by which regulate DNA damage checkpoints in mammals
-
批准号:13470027
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2001
-
负责人:NAKANISHI Makoto
-
依托单位:
Regulation of cell cycle checkpoints that monitor DNA damage and DNA replication block.
-
批准号:13043043
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$45.57万
-
财政年份:2001
-
负责人:NAKANISHI Makoto
-
依托单位:
国内基金
海外基金
NK细胞抑制性受体CD96作为肝癌checkpoint免疫治疗靶点的进一步验证
-
批准号:81972679
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:孙昊昱
-
依托单位: